• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌呼吸链的可塑性及其对结核病药物开发的影响。

Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development.

机构信息

Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY, 10065, USA.

School of Biomedical Sciences, University of Queensland, Brisbane, 4072, Australia.

出版信息

Nat Commun. 2019 Oct 31;10(1):4970. doi: 10.1038/s41467-019-12956-2.

DOI:10.1038/s41467-019-12956-2
PMID:31672993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6823465/
Abstract

The viability of Mycobacterium tuberculosis (Mtb) depends on energy generated by its respiratory chain. Cytochrome bc1-aa3 oxidase and type-2 NADH dehydrogenase (NDH-2) are respiratory chain components predicted to be essential, and are currently targeted for drug development. Here we demonstrate that an Mtb cytochrome bc1-aa3 oxidase deletion mutant is viable and only partially attenuated in mice. Moreover, treatment of Mtb-infected marmosets with a cytochrome bc1-aa3 oxidase inhibitor controls disease progression and reduces lesion-associated inflammation, but most lesions become cavitary. Deletion of both NDH-2 encoding genes (Δndh-2 mutant) reveals that the essentiality of NDH-2 as shown in standard growth media is due to the presence of fatty acids. The Δndh-2 mutant is only mildly attenuated in mice and not differently susceptible to clofazimine, a drug in clinical use proposed to engage NDH-2. These results demonstrate the intrinsic plasticity of Mtb's respiratory chain, and highlight the challenges associated with targeting the pathogen's respiratory enzymes for tuberculosis drug development.

摘要

结核分枝杆菌(Mtb)的生存能力取决于其呼吸链产生的能量。细胞色素 bc1-aa3 氧化酶和型 2NADH 脱氢酶(NDH-2)是预测为必需的呼吸链成分,目前是药物开发的目标。在这里,我们证明了 Mtb 细胞色素 bc1-aa3 氧化酶缺失突变体在小鼠中是可行的,并且仅部分减毒。此外,用细胞色素 bc1-aa3 氧化酶抑制剂治疗感染狨猴的结核分枝杆菌可控制疾病进展并减少病变相关炎症,但大多数病变会形成空洞。删除两个 NDH-2 编码基因(Δndh-2 突变体)表明,在标准生长培养基中显示的 NDH-2 的必需性是由于脂肪酸的存在。Δndh-2 突变体在小鼠中仅轻度减毒,并且对氯法齐明(一种用于临床的拟议与 NDH-2 结合的药物)的敏感性没有差异。这些结果表明了 Mtb 呼吸链的内在可塑性,并强调了针对病原体呼吸酶进行结核病药物开发所面临的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/874cf582795c/41467_2019_12956_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/1e2d9c91a2cf/41467_2019_12956_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/c8263a4981c4/41467_2019_12956_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/6a633f0a6ba6/41467_2019_12956_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/4f9909c04465/41467_2019_12956_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/ff47cfe49f26/41467_2019_12956_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/874cf582795c/41467_2019_12956_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/1e2d9c91a2cf/41467_2019_12956_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/c8263a4981c4/41467_2019_12956_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/6a633f0a6ba6/41467_2019_12956_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/4f9909c04465/41467_2019_12956_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/ff47cfe49f26/41467_2019_12956_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b7a/6823465/874cf582795c/41467_2019_12956_Fig6_HTML.jpg

相似文献

1
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development.结核分枝杆菌呼吸链的可塑性及其对结核病药物开发的影响。
Nat Commun. 2019 Oct 31;10(1):4970. doi: 10.1038/s41467-019-12956-2.
2
Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc:aa in Mycobacterium tuberculosis.碳代谢调节针对结核分枝杆菌细胞色素 bc:aa 的药物的疗效。
Sci Rep. 2019 Jun 13;9(1):8608. doi: 10.1038/s41598-019-44887-9.
3
Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.结核分枝杆菌中细胞色素C氧化酶受抑制时的呼吸灵活性
Antimicrob Agents Chemother. 2014 Nov;58(11):6962-5. doi: 10.1128/AAC.03486-14. Epub 2014 Aug 25.
4
Exploiting the synthetic lethality between terminal respiratory oxidases to kill and clear host infection.利用末端呼吸氧化酶之间的合成致死性来杀死和清除宿主感染。
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7426-7431. doi: 10.1073/pnas.1706139114. Epub 2017 Jun 26.
5
Targeting the Mycobacterium ulcerans cytochrome bc:aa for the treatment of Buruli ulcer.针对溃疡分枝杆菌细胞色素 bc:aa 治疗皮肤利什曼病。
Nat Commun. 2018 Dec 18;9(1):5370. doi: 10.1038/s41467-018-07804-8.
6
Cytochrome bc1-aa3 Oxidase Supercomplex As Emerging and Potential Drug Target Against Tuberculosis.细胞色素 bc1-aa3 氧化酶超复合体作为抗结核的新兴和潜在药物靶点。
Curr Mol Pharmacol. 2022;15(2):380-392. doi: 10.2174/1874467214666210928152512.
7
Plasticity of NADH dehydrogenases and their role in virulence.NADH 脱氢酶的可塑性及其在毒力中的作用。
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1599-1604. doi: 10.1073/pnas.1721545115. Epub 2018 Jan 30.
8
Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.II型烟酰胺腺嘌呤二核苷酸脱氢酶(NDH-2):抗结核和抗菌药物研发中一个有前景的治疗靶点。
Expert Opin Ther Targets. 2017 Jun;21(6):559-570. doi: 10.1080/14728222.2017.1327577. Epub 2017 May 15.
9
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.芳基乙烯基哌嗪酰胺,一种针对结核分枝杆菌 QcrB 的新型强效抑制剂。
mBio. 2018 Oct 9;9(5):e01276-18. doi: 10.1128/mBio.01276-18.
10
Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa3.由结核分枝杆菌细胞色素bcc和耻垢分枝杆菌细胞色素aa3组成的混合呼吸超复合物的分离与鉴定
J Biol Chem. 2015 Jun 5;290(23):14350-60. doi: 10.1074/jbc.M114.624312. Epub 2015 Apr 10.

引用本文的文献

1
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype.基于吡咯并喹诺酮的化合物作为一种新型抗分枝杆菌化学类型
ACS Med Chem Lett. 2025 Jun 3;16(6):1139-1146. doi: 10.1021/acsmedchemlett.5c00183. eCollection 2025 Jun 12.
2
Proton gradient controls the lateral rearrangement of inner membrane domains in response to membrane fluidizer stress in Mycobacterium smegmatis.质子梯度控制耻垢分枝杆菌内膜结构域在膜流化应激下的侧向重排。
J Biol Chem. 2025 Jun 11;301(7):110361. doi: 10.1016/j.jbc.2025.110361.
3
The effects of silver nitrate on biofilms in a simulated antimicrobial showerhead environment.

本文引用的文献

1
Targeting the Mycobacterium ulcerans cytochrome bc:aa for the treatment of Buruli ulcer.针对溃疡分枝杆菌细胞色素 bc:aa 治疗皮肤利什曼病。
Nat Commun. 2018 Dec 18;9(1):5370. doi: 10.1038/s41467-018-07804-8.
2
Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis.用于治疗耐药结核病的呼吸细胞色素bcc复合物的吡唑并[1,5-a]吡啶抑制剂
ACS Infect Dis. 2019 Feb 8;5(2):239-249. doi: 10.1021/acsinfecdis.8b00225. Epub 2018 Dec 11.
3
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
硝酸银在模拟抗菌淋浴喷头环境中对生物膜的影响。
Front Public Health. 2025 May 26;13:1572869. doi: 10.3389/fpubh.2025.1572869. eCollection 2025.
4
Chalkophore-mediated respiratory oxidase flexibility controls virulence.载铜细胞色素介导的呼吸氧化酶灵活性控制毒力。
Elife. 2025 Jun 5;14:RP105794. doi: 10.7554/eLife.105794.
5
Efficacy of novel regimens targeting oxidative phosphorylation in .针对氧化磷酸化的新型治疗方案在……中的疗效
Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0001925. doi: 10.1128/aac.00019-25. Epub 2025 Apr 22.
6
Mycobactin and clofazimine activity are negatively correlated in mycobacteria.在分枝杆菌中,分枝杆菌素与氯法齐明活性呈负相关。
Front Microbiol. 2025 Apr 3;16:1539139. doi: 10.3389/fmicb.2025.1539139. eCollection 2025.
7
Cryo-EM of native membranes reveals an intimate connection between the Krebs cycle and aerobic respiration in mycobacteria.天然膜的冷冻电镜技术揭示了分枝杆菌中三羧酸循环与有氧呼吸之间的紧密联系。
Proc Natl Acad Sci U S A. 2025 Feb 25;122(8):e2423761122. doi: 10.1073/pnas.2423761122. Epub 2025 Feb 19.
8
Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals.了解结核性肉芽肿的发展:对宿主保护和发病机制的见解,人类和动物研究综述
Front Immunol. 2024 Dec 9;15:1427559. doi: 10.3389/fimmu.2024.1427559. eCollection 2024.
9
Interplay of niche and respiratory network in shaping bacterial colonization.生态位与呼吸网络在塑造细菌定殖过程中的相互作用。
J Biol Chem. 2025 Jan;301(1):108052. doi: 10.1016/j.jbc.2024.108052. Epub 2024 Dec 9.
10
Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research.对抗抗菌药物耐药性:抗菌研究中的创新药物
Angew Chem Int Ed Engl. 2025 Mar 3;64(10):e202414325. doi: 10.1002/anie.202414325. Epub 2025 Feb 10.
芳基乙烯基哌嗪酰胺,一种针对结核分枝杆菌 QcrB 的新型强效抑制剂。
mBio. 2018 Oct 9;9(5):e01276-18. doi: 10.1128/mBio.01276-18.
4
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization.2-巯基喹唑啉酮作为Ⅱ型烟酰胺腺嘌呤二核苷酸脱氢酶和结核分枝杆菌的抑制剂:构效关系、作用机制及吸收、分布、代谢和排泄特征
ACS Infect Dis. 2018 Jun 8;4(6):954-969. doi: 10.1021/acsinfecdis.7b00275. Epub 2018 Mar 26.
5
Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity.小分子靶向结核分枝杆菌 II 型 NADH 脱氢酶表现出抗分枝杆菌活性。
Angew Chem Int Ed Engl. 2018 Mar 19;57(13):3478-3482. doi: 10.1002/anie.201800260. Epub 2018 Feb 22.
6
Plasticity of NADH dehydrogenases and their role in virulence.NADH 脱氢酶的可塑性及其在毒力中的作用。
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1599-1604. doi: 10.1073/pnas.1721545115. Epub 2018 Jan 30.
7
Variant Review with the Integrative Genomics Viewer.使用综合基因组浏览器进行变异审查。
Cancer Res. 2017 Nov 1;77(21):e31-e34. doi: 10.1158/0008-5472.CAN-17-0337.
8
Susceptibility of Mycobacterium tuberculosis Cytochrome Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome .结核分枝杆菌细胞色素氧化酶突变体对靶向末端呼吸氧化酶细胞色素的化合物的敏感性。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01338-17. Print 2017 Oct.
9
Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.乙胺丁醇在结核性肺病变中的分配解释了其临床疗效。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00924-17. Print 2017 Sep.
10
Exploiting the synthetic lethality between terminal respiratory oxidases to kill and clear host infection.利用末端呼吸氧化酶之间的合成致死性来杀死和清除宿主感染。
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7426-7431. doi: 10.1073/pnas.1706139114. Epub 2017 Jun 26.